Eternity Insights has published a new study on Global Diabetes Devices Market focusing on key segments as By Type (BGM Devices, Insulin Delivery Devices), By Distribution Channel (Hospital pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies, Others), By End-Use (Hospitals, Homecare, Diagnostic Centers), and by region. This deep dive research report highlights the market and competitive intelligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Diabetes Devices Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Diabetes Devices Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Diabetes Devices market in terms of demand generation. The Diabetes Devices market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Diabetes Devices market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
To learn more about this report
The global Diabetes Devices market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | BGM Devices, Insulin Delivery Devices |
| By End-Use Outlook | Hospitals, Homecare, Diagnostic Centers |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | Medtronic plc, Abbott Laboratories, Hoffmann-La-Ltd., Bayer AG, Lifescan, Inc., B Braun Melsungen AG, Lifescan, Inc., Dexcom Inc., Insulet Corporation, Ypsomed Holdings, Companion Medical, Sanofi, Valeritas Holding Inc., Novo Nordisk, Arkray, Inc. |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
Table of Contents
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Diabetes Devices Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Insulin Delivery Devices Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
2.2 Glucose Monitoring Devices Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
2.3 Artificial Pancreas System Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
2.4 Other Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
3 Asia Pacific Diabetes Devices Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Diabetes Devices Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Diabetes Devices Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Diabetes Devices Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Diabetes Devices Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Diabetes Devices Market Assessment by Type
8.1 Asia Pacific Diabetes Devices Market Assessment by Application (Consumption and Market Share)
8.2 North America Diabetes Devices Market Assessment by Application (Consumption and Market Share)
8.3 Europe Diabetes Devices Market Assessment by Application (Consumption and Market Share)
8.4 South America Diabetes Devices Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Diabetes Devices Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Medtronic
9.1.1 Medtronic Profiles
9.1.2 Medtronic Product Portfolio
9.1.3 Medtronic Diabetes Devices Business Performance
9.1.4 Medtronic Diabetes Devices Business Development and Market Status
9.2 Sanofi
9.2.1 Sanofi Profiles
9.2.2 Sanofi Product Portfolio
9.2.3 Sanofi Diabetes Devices Business Performance
9.2.4 Sanofi Diabetes Devices Business Development and Market Status
9.3 Novo Nordisk
9.3.1 Novo Nordisk Profiles
9.3.2 Novo Nordisk Product Portfolio
9.3.3 Novo Nordisk Diabetes Devices Business Performance
9.3.4 Novo Nordisk Diabetes Devices Business Development and Market Status
9.4 Eli Lilly and Company
9.4.1 Eli Lilly and Company Profiles
9.4.2 Eli Lilly and Company Product Portfolio
9.4.3 Eli Lilly and Company Diabetes Devices Business Performance
9.4.4 Eli Lilly and Company Diabetes Devices Business Development and Market Status
9.5 Roche
9.5.1 Roche Profiles
9.5.2 Roche Product Portfolio
9.5.3 Roche Diabetes Devices Business Performance
9.5.4 Roche Diabetes Devices Business Development and Market Status
9.6 Medtronic
9.6.1 Medtronic Profiles
9.6.2 Medtronic Product Portfolio
9.6.3 Medtronic Diabetes Devices Business Performance
9.6.4 Medtronic Diabetes Devices Business Development and Market Status
9.7 Baxter
9.7.1 Baxter Profiles
9.7.2 Baxter Product Portfolio
9.7.3 Baxter Diabetes Devices Business Performance
9.7.4 Baxter Diabetes Devices Business Development and Market Status
9.8 Arkray
9.8.1 Arkray Profiles
9.8.2 Arkray Product Portfolio
9.8.3 Arkray Diabetes Devices Business Performance
9.8.4 Arkray Diabetes Devices Business Development and Market Status
10 World Diabetes Devices Market Assessment by Players
10.1 Global Diabetes Devices Sales (K Units) and Market Share by Players 2017-2020
10.2 Global Diabetes Devices Revenue (M USD) and Market Share by Players 2017-2020
10.3 Global Diabetes Devices Price (USD/Unit) of Players 2017-2020
10.4 Global Diabetes Devices Gross Margin of Players 2017-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Diabetes Devices Sales Assessment of Players 2017-2020
11.1.2 North America Diabetes Devices Revenue Assessment of Players 2017-2020
11.1.3 North America Diabetes Devices Price Assessment of Players 2017-2020
11.1.4 North America Diabetes Devices Gross Margin Assessment of Players 2017-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Diabetes Devices Sales Assessment of Players 2017-2020
11.2.2 Europe Diabetes Devices Revenue Assessment of Players of Manufacturers 2017-2020
11.2.3 Europe Diabetes Devices Price Assessment of Players 2017-2020
11.2.4 Europe Diabetes Devices Gross Margin Assessment of Players 2017-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Diabetes Devices Sales Assessment of Players 2017-2020
11.3.2 Asia-Pacific Diabetes Devices Revenue Assessment of Players 2017-2020
11.3.3 Asia-Pacific Diabetes Devices Price Assessment of Players 2017-2020
11.3.4 Asia-Pacific Diabetes Devices Gross Margin Assessment of Players 2017-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Diabetes Devices Sales Assessment of Players 2017-2020
11.4.2 South America Diabetes Devices Revenue Assessment of Players 2017-2020
11.4.3 South America Diabetes Devices Price Assessment of Players 2017-2020
11.4.4 South America Diabetes Devices Gross Margin Assessment of Players 2017-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Diabetes Devices Sales Assessment of Players 2017-2020
11.5.2 Middle East and Africa Diabetes Devices Revenue Assessment of Players 2017-2020
11.5.3 Middle East and Africa Diabetes Devices Price Assessment of Players 2017-2020
11.5.4 Middle East and Africa Diabetes Devices Gross Margin Assessment of Players 2017-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Diabetes Devices Sales by Countries/Regions 2017-2020
12.1.2 Asia Pacific Diabetes Devices Revenue by Countries/Regions 2017-2020
12.1.3 Asia Pacific Diabetes Devices Average Price by Countries/Regions 2017-2020
12.2 North America
12.2.1 North America Diabetes Devices Sales by Countries/Regions 2017-2020
12.2.2 North America Diabetes Devices Revenue by Countries/Regions 2017-2020
12.2.3 North America Diabetes Devices Average Price by Countries/Regions 2017-2020
12.3 Europe
12.3.1 Europe Diabetes Devices Sales by Countries/Regions 2017-2020
12.3.2 Europe Diabetes Devices Revenue by Countries/Regions 2017-2020
12.3.3 Europe Diabetes Devices Average Price by Countries/Regions 2017-2020
12.4 South America
12.4.1 South America Diabetes Devices Sales by Countries/Regions 2017-2020
12.4.2 South America Diabetes Devices Revenue by Countries/Regions 2017-2020
12.4.3 South America Diabetes Devices Average Price by Countries/Regions 2017-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Diabetes Devices Sales by Countries/Regions 2017-2020
12.5.2 Middle East and Africa Diabetes Devices Revenue by Countries/Regions 2017-2020
12.5.3 Middle East and Africa Diabetes Devices Average Price by Countries/Regions 2017-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Diabetes Devices Sales & Revenue Forecast 2021-2027
14.1 World Diabetes Devices Sales and Revenue Forecast by Regions 2021-2027
14.1.1 World Diabetes DevicesSales and Market Share by Regions
14.1.2 World Diabetes DevicesRevenue and Market Share by Regions
15 Asia Diabetes Devices Market Forecast 2021-2027
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2027
15.1.1 Insulin Delivery Devices
15.1.2 Glucose Monitoring Devices
15.1.3 Artificial Pancreas System
15.1.4 Other
15.2 Consumption Forecast by Application, 2021-2027
16 North America Diabetes Devices Market Forecast 2021-2027
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2027
16.1.1 Insulin Delivery Devices
16.1.2 Glucose Monitoring Devices
16.1.3 Artificial Pancreas System
16.1.4 Other
16.2 Consumption Forecast by Application, 2021-2027
17 Europe Diabetes Devices Market Forecast 2021-2027
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2027
17.1.1 Insulin Delivery Devices
17.1.2 Glucose Monitoring Devices
17.1.3 Artificial Pancreas System
17.1.4 Other
17.2 Consumption Forecast by Application, 2021-2027
18 South America Diabetes Devices Market Forecast 2021-2027
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2027
18.1.1 Insulin Delivery Devices
18.1.2 Glucose Monitoring Devices
18.1.3 Artificial Pancreas System
18.1.4 Other
18.2 Consumption Forecast by Application, 2021-2027
19 Middle East and Africa Diabetes Devices Market Forecast 2021-2027
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2027
19.1.1 Insulin Delivery Devices
19.1.2 Glucose Monitoring Devices
19.1.3 Artificial Pancreas System
19.1.4 Other
19.2 Consumption Forecast by Application, 2021-2027
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Diabetes Devices Price (USD/Unit) Trend 2021-2027
20.2 Global Diabetes Devices Gross Profit Trend 2021-2027
21 Conclusion
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
A faster and efficient way to cater to the needs with continuous iteration
Focus on Data Accuracy & Reliability
75+ Clients in Fortune 500
All your transactions are secured end-to-end, ensuring a satisfactory purchase
Ensure the best and affordable pricing
